Method for the stereoselective preparation of amino acid derivatives
Abstract
The invention relates to a process for the stereoselective preparation of amino acid derivatives, comprising a hydrogenation reaction of the compound of formula (III), alternatively its enantiomer, wherein R is (C 1 -C 8 )-alkyl; followed by a hydrolysis reaction to obtain L-mesityl alanine, alternatively its enantiomer D-mesityl alanine and, optionally, subjecting said compound to an amino group protection reaction, particularly as Fmoc. It also comprises Fmoc-L- or Fmoc-D- mesityl alanine as products per se, useful as intermediates in preparing peptides or peptide analogs with therapeutic or biological activity.
Claims
exact text as granted — not AI-modified1 . Fmoc-(L)-mesityl alanine with an enantiomeric purity of >99% enantiomeric excess.
2 . Fmoc-(D)-mesityl alanine with an enantiomeric purity of >99% enantiomeric excess.
3 . A process for preparing peptides and/or peptide analogs with one or more mesityl alanine residues, comprising the following steps:
a. Solid phase synthesis of the peptide, incorporating the mesityl alanine residues in the form of enantiomerically pure Fmoc-(L)-mesityl alanine and/or Fmoc-(D)-mesityl alanine according to any of claims 1 and 2 , and b. Cleaving the peptide from the polymeric support and simultaneously eliminating the protecting groups of the amino acids.
4 . The process according to claim 3 , wherein the process is performed on an industrial scale.Join the waitlist — get patent alerts
Track US2014303344A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.